Sudipta Bhattacharya

Learn More
OBJECTIVE To evaluate the efficacy and long-term safety of linagliptin added to basal insulins in type 2 diabetes inadequately controlled on basal insulin with or without oral agents. RESEARCH DESIGN AND METHODS A total of 1,261 patients (HbA1c ≥7.0% [53 mmol/mol] to ≤10.0% [86 mmol/mol]) on basal insulin alone or combined with metformin and/or(More)
BACKGROUND Addition of a sulphonylurea to metformin improves glycaemic control in type 2 diabetes, but is associated with hypoglycaemia and weight gain. We aimed to compare a dipeptidyl peptidase-4 inhibitor (linagliptin) against a commonly used sulphonylurea (glimepiride). METHODS In this 2-year, parallel-group, non-inferiority double-blind trial,(More)
The advent of asynchronous web based learning systems has helped the learner in a self paced, personalized and flexible learning style. It can be even more useful with a supportive synchronous tutorial (question-answer) session. The challenge is to provide sufficient information to the instructor about the learner's experience in that particular course at(More)
  • 1